Welcome to our dedicated page for Cbdmd news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on Cbdmd stock.
cbdMD, Inc. (NYSE American: YCBD) generates a steady flow of corporate, financial, and strategic news tied to its position in the hemp-derived wellness and cannabinoid products space. Company press releases and SEC filings highlight developments across its cbdMD and Paw CBD brands, ATRx Labs functional mushroom products, and Herbal Oasis hemp-derived THC social seltzers, as well as capital markets activity and exchange-listing matters.
News for YCBD often covers operating performance, including updates on net sales, gross profit, and operating loss trends disclosed in conjunction with annual and quarterly results. The company has reported multiple years of operating improvement and has discussed cost management, product portfolio optimization, and marketing investments in its communications. Investors following YCBD news also see disclosures about preferred stock financings, such as Series B and Series C Convertible Preferred Stock, and the establishment of an equity line of credit registered on Form S-1.
Regulatory and listing-related announcements form another key part of cbdMD’s news flow. The company has reported regaining full compliance with NYSE American continued listing standards after addressing equity-related deficiencies, and it has furnished related information through Form 8-K filings. Policy commentary around federal discussions on cannabinoids and hemp-derived products, and how those discussions may affect research and investment in the category, also appears in its releases.
Strategic updates, including the asset acquisition of Gaia Botanicals, LLC and its Bluebird Botanicals brand and online CBD marketplace, are disclosed through press releases and 8-K filings. These items provide detail on how cbdMD is expanding its brand portfolio, intellectual property base, and product offerings in CBD and related categories. For investors and observers, the YCBD news page offers a centralized view of earnings communications, capital transactions, regulatory milestones, and brand-level initiatives across cbdMD’s wellness platform.
cbdMD (NYSE American: YCBD) has launched Inferno Freeze, its most powerful topical product designed for athletes and fitness enthusiasts. The new product features an advanced full-spectrum formula containing 3000mg CBD, 500mg CBDa, and 50mg THC combined with cooling agents including 4% Menthol, 3% Camphor, and 0.04% Capsaicin.
The product utilizes nano-technology for enhanced absorption and effectiveness, incorporating USA-grown hemp and non-GMO ingredients. This launch expands cbdMD's topicals line and complements their existing portfolio of ingestibles, pet products, functional mushrooms, and hemp-derived beverages.
Herbal Oasis (NYSE:YCBD), a hemp-derived THC-infused social seltzer brand, has announced its expansion into Minnesota through a new partnership with Global Reserve Distribution (GRD). This strategic move marks the company's first expansion beyond its Southeast market base.
The expansion comes as the THC beverage market shows significant growth, with U.S. THC Beverage sales reaching $1.1 billion in 2024 and projected to grow by over 25% in 2025. The market is expected to triple by 2030. Herbal Oasis differentiates itself with beverages infused with THC, CBG, and adaptogenic mushrooms, targeting consumers seeking alternatives to alcohol and traditional cannabis products.
Herbal Oasis (NYSE:YCBD) has announced a strategic distribution partnership with Best Brands to expand its THC-infused seltzer products into Tennessee. This expansion follows successful launches in Alabama, Florida, Georgia, and North Carolina, marking the company's growing presence in the Southeast region.
The partnership comes amid significant growth in the THC beverage market, with Brightfield projecting 50% growth in US Sales to over $571 million in 2025. Herbal Oasis's products, infused with THC, CBG, and functional mushrooms, are positioned as modern alternatives to alcohol for consumers seeking clarity and connection.
cbdMD (NYSE American: YCBD) reported Q3 2025 financial results with revenue of $4.6 million, down 10.9% from $5.2 million in the prior year period. The company's operating loss widened to $905,000 from $382,000 year-over-year, while gross margin decreased from 66% to 61%.
Key developments include the completion of a marketing team overhaul, expansion of Herbal Oasis beverage brand into 7 states, and the conversion of Series A Preferred Stock which eliminated $6.7 million in accrued dividend liability. The company's book value increased to $6.1 million as of June 30, 2025, up from $0.67 million in March 2025.
Direct-to-consumer sales represented 78% of total revenue at $3.6 million, while wholesale revenue contributed 22% at $1.0 million. The company ended the quarter with $1.1 million in cash and working capital of $2.0 million.
cbdMD (NYSE American: YCBD), a leading CBD company, has scheduled a conference call to discuss its Q3 FY2025 financial results for the period ending June 30, 2025. The call will take place on Thursday, August 14, 2025, at 4:20 p.m. Eastern Time.
Investors can access the call through multiple channels including USA/Canada (833-821-3524) and International (647-846-2919) dial-in numbers. A replay will be available with passcode 5327882, and the webcast replay will remain accessible through August 15, 2026, via the provided link.
cbdMD (NYSE American: YCBD) has announced the retail launch of its Herbal Oasis Social Tonics at select Total Wine locations in Charlotte and surrounding North Carolina areas. The hemp-derived THC seltzers, initially launched in late 2024, feature a unique blend of functional mushrooms, adaptogens, and nootropics including Lion's Mane, Reishi, Cordyceps, and Maitake.
The product line offers four flavors - Berry Fusion, Lemon Lift, Mango Bliss, and Tropical Twist - and is positioned as a low-calorie alternative to alcoholic beverages. Each drink is enhanced with L-theanine and B12, designed to provide calm energy and social clarity.
Herbal Oasis, a hemp-derived THC-infused social seltzer brand owned by cbdMD (YCBD), has announced a new distribution partnership with Beverage South to expand its presence in Georgia. This marks the company's fourth state expansion in two months, following launches in Alabama, Florida, and North Carolina.
The partnership strengthens Oasis's footprint in the Southeast region, aligning with their goal of becoming the leading THC seltzer brand. The THC beverage market is projected to grow by 50% in 2025, reaching $571 million in US sales according to Brightfield estimates. Oasis's products are infused with THC, CBG, and functional mushrooms, positioning themselves as an alcohol alternative focused on presence, clarity, and social connection.
cbdMD, Inc. (NYSE American: YCBD), a leading CBD company, has announced it will host a conference call to discuss its second quarter fiscal year 2025 financial results for the period ending March 31, 2025. The conference call is scheduled for Thursday, May 15, 2025, at 4:20 p.m. Eastern Time. Participants can join via USA/Canada (833-821-3524) or International (647-846-2919) dial-in numbers. A replay will be available through dedicated phone lines and a webcast replay link will remain accessible until May 15, 2026.
Herbal Oasis, a hemp-derived THC-infused social seltzer brand owned by cbdMD (YCBD), has announced a new distribution agreement with Carolina Premium Beverage to serve Charlotte, NC and surrounding counties starting May 2025. This expansion marks the brand's entry into its third state in two months, following successful launches in Alabama and Florida.
The beverage brand, targeting sober-curious and health-conscious consumers, combines hemp-derived THC, CBG, and functional mushrooms to create an alcohol alternative. The partnership with Carolina Premium Beverage aims to accelerate market penetration in Charlotte, the company's home territory, while supporting its broader Southeast expansion strategy.